128 related articles for article (PubMed ID: 2338290)
1. Ceftriaxone and amikacin as single daily dose in the empiric therapy for febrile episodes in neutropenic patients.
Martino P; Girmenia C; Raccah R; Micozzi A; Cimino G; Mandelli F
Haematologica; 1990; 75(1):69-74. PubMed ID: 2338290
[TBL] [Abstract][Full Text] [Related]
2. Ceftriaxone plus amikacin in neutropenic patients: a report on 100 cases.
Blanc C; Pollet JP; Bauters F
Chemotherapy; 1991; 37(5):382-8. PubMed ID: 1804600
[TBL] [Abstract][Full Text] [Related]
3. Prophylaxis, cost and effectiveness of therapy of infections caused by gram-positive organisms in neutropenic children.
Schaison GS; Decroly FC
J Antimicrob Chemother; 1991 Apr; 27 Suppl B():61-7. PubMed ID: 1829078
[TBL] [Abstract][Full Text] [Related]
4. Treatment of febrile episodes in neutropenic leukemic patients with the antibiotic combinations piperacillin or ceftazidime plus amikacin: results of a randomized study.
Fenu S; Raccah R; Santilli S; Micozzi A; Girmena C; Martino P; Avvisati G
Chemioterapia; 1988 Oct; 7(5):323-6. PubMed ID: 3066517
[TBL] [Abstract][Full Text] [Related]
5. Randomized clinical trial comparing ceftriaxone/amikacin versus ceftazidime/amikacin as initial therapy of febrile episodes in neutropenic patients.
Yataganas X; Rombos Y; Vayopoulos G; Meletis J; Avlami A
Chemotherapy; 1991; 37(5):376-81. PubMed ID: 1804599
[TBL] [Abstract][Full Text] [Related]
6. Empirical antibiotic therapy in febrile neutropenic patients with single-daily dose amikacin plus ceftriaxone.
Suwangool P; Aswapokee N; Sathapatayavongs B; Leelasuphasri S; Siritanaratkul N; Chuncharunee S; Chayakul P
J Med Assoc Thai; 1993 Jun; 76(6):314-8. PubMed ID: 8083623
[TBL] [Abstract][Full Text] [Related]
7. A prospective, controlled, randomized, non-blind, comparative study of the efficacy and safety of a once daily high dose of ceftriaxone plus ciprofloxacin versus thrice daily ceftazidime plus amikacin in empirical therapy for febrile neutropenic patients.
Metallidis S; Kollaras P; Giannakakis T; Seitanidis B; Kordosis T; Nikolaidis J; Hatzitolios A; Nikolaidis P
Eur J Intern Med; 2008 Dec; 19(8):619-24. PubMed ID: 19046729
[TBL] [Abstract][Full Text] [Related]
8. Ceftriaxone and amikacin versus ceftazidime and amikacin in febrile granulocytopenia.
Schmid L; Jeschko M; Wilder-Smith C; Schafroth U; Thürlimann B; Pedrazzini A; Senn H
Chemotherapy; 1991; 37(5):346-52. PubMed ID: 1804595
[TBL] [Abstract][Full Text] [Related]
9. Isepamicin once daily plus ceftriaxone versus amikacin plus ceftriaxone in febrile neutropenic patients.
Herbrecht R; Blaise D; Espinouse D; Leblond V; Sadoun A; Sauvage C; Cordonnier C; Minozzi C
J Chemother; 1995 Jun; 7 Suppl 2():103-10. PubMed ID: 8622099
[TBL] [Abstract][Full Text] [Related]
10. Effects of teicoplanin and those of vancomycin in initial empirical antibiotic regimen for febrile, neutropenic patients with hematologic malignancies. Gimema Infection Program.
Menichetti F; Martino P; Bucaneve G; Gentile G; D'Antonio D; Liso V; Ricci P; Nosari AM; Buelli M; Carotenuto M
Antimicrob Agents Chemother; 1994 Sep; 38(9):2041-6. PubMed ID: 7811016
[TBL] [Abstract][Full Text] [Related]
11. Netilmicin plus ceftriaxone versus amikacin plus ceftriaxone in the treatment of infections in granulocytopenic patients.
Krcméry V; Koza I; Mardiak J; Fuchsberger P; Spánik S; Trupl J; Horníková M; Kusenda Z; Sufliarsky J; Svec J
Chemotherapy; 1992; 38(1):74-6. PubMed ID: 1618007
[TBL] [Abstract][Full Text] [Related]
12. Aztreonam plus vancomycin (plus amikacin) vs. moxalactam plus ticarcillin for the empiric treatment of febrile episodes in neutropenic cancer patients.
Jones P; Rolston K; Fainstein V; Elting L; Bodey GP
Rev Infect Dis; 1985; 7 Suppl 4():S741-6. PubMed ID: 3909332
[TBL] [Abstract][Full Text] [Related]
13. Using teicoplanin for empiric therapy of febrile neutropenic patients with haematological malignancies.
Menichetti F; Del Favero A; Bucaneve G; Aversa F; Fiorio M
Br J Haematol; 1990 Dec; 76 Suppl 2():45-8. PubMed ID: 2149052
[TBL] [Abstract][Full Text] [Related]
14. Empirical antimicrobial therapy with a single daily dose of ceftriaxone plus amikacin in febrile granulocytopenic patients: a pilot study.
Meunier F; Van der Auwera P; Aoun M; Ibrahim S; Tulkens PM
J Antimicrob Chemother; 1991 May; 27 Suppl C():129-39. PubMed ID: 1856142
[TBL] [Abstract][Full Text] [Related]
15. Piperacillin/tazobactam/amikacin versus piperacillin/amikacin/teicoplanin in the empirical treatment of neutropenic patients.
Micozzi A; Nucci M; Venditti M; Gentile G; Girmenia C; Meloni G; Martino P
Eur J Clin Microbiol Infect Dis; 1993 Jan; 12(1):1-8. PubMed ID: 8385015
[TBL] [Abstract][Full Text] [Related]
16. [Antibiotic therapy protocol using ceftazidime 3g/day alone or in combination with vancomycin or amikacin. In febrile episodes in neutropenic patients].
Marie JP; Pico JL; Chiche D; Fitoussi F; Delmer A; Baume D; Rio B; Ajchenbaum F; Richet H; Tancrède C
Presse Med; 1988 Oct; 17(37):1968-70. PubMed ID: 2973598
[TBL] [Abstract][Full Text] [Related]
17. Single daily dose ceftriaxone plus amikacin treatment of febrile episodes in neutropenic patients attending day hospital for hematologic malignancies.
Martino P; Girmenia C; Raccah R; Micozzi A; Cimino G; Sgadari C; Gentile G
Oncology; 1992; 49(1):49-52. PubMed ID: 1542494
[TBL] [Abstract][Full Text] [Related]
18. [The use of teicoplanin in neutropenic patients: values and limits].
Espinouse D; Chomarat M
Pathol Biol (Paris); 1990 Jun; 38(5 ( Pt 2)):552-6. PubMed ID: 2143573
[TBL] [Abstract][Full Text] [Related]
19. Out-patient management of acute myeloid leukemia after consolidation chemotherapy. Role of a hematologic emergency unit.
Girmenia C; Alimena G; Latagliata R; Morano SG; Celesti F; Coppola L; Spadea A; Tosti S; Mecarocci S; D'Elia GM; Tafuri A; Cimino G; Mandelli F
Haematologica; 1999 Sep; 84(9):814-9. PubMed ID: 10477455
[TBL] [Abstract][Full Text] [Related]
20. [Prospective and comparative study of 2 antibiotic therapy protocols in 66 febrile neutropenic patients. Ceftazidime-vancomycin versus ticarcillin-vancomycin-amikacin].
Brion JP; Bru JP; Michallet M; Corron B; Fauconnier J
Presse Med; 1988 Oct; 17(37):1964-7. PubMed ID: 2973597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
